Counteracting Colon Cancer by Inhibiting Mitochondrial Respiration and Glycolysis with a Selective PKCδ Activator

Metabolic reprogramming is a central hub in tumor development and progression. Therefore, several efforts have been developed to find improved therapeutic approaches targeting cancer cell metabolism. Recently, we identified the 7α-acetoxy-6β-benzoyloxy-12-O-benzoylroyleanone (Roy-Bz) as a PKCδ-selec...

Descripción completa

Detalles Bibliográficos
Autores principales: Bessa, Cláudia, Loureiro, Joana B., Barros, Matilde, Isca, Vera M. S., Sardão, Vilma A., Oliveira, Paulo J., Bernardino, Raquel L., Herman-de-Sousa, Carina, Costa, Maria Adelina, Correia-de-Sá, Paulo, Alves, Marco G., Rijo, Patrícia, Saraiva, Lucília
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054007/
https://www.ncbi.nlm.nih.gov/pubmed/36982784
http://dx.doi.org/10.3390/ijms24065710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054007/
https://www.ncbi.nlm.nih.gov/pubmed/36982784
http://dx.doi.org/10.3390/ijms24065710

Ejemplares similares